LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.67
+0.40 (5.50%)
At close: Apr 28, 2026, 4:00 PM EDT
7.72
+0.05 (0.65%)
After-hours: Apr 28, 2026, 7:58 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for LifeStance Health Group stock have an average target of 9.83, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 28.16% from the current stock price of 7.67.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2026.
Analyst Ratings
The average analyst rating for LifeStance Health Group stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 2 | 3 | 3 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +17.34% | Mar 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +30.38% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +56.45% | Feb 26, 2026 |
| Keybanc | Keybanc | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +17.34% | Feb 26, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +43.42% | Feb 2, 2026 |
Financial Forecast
Revenue This Year
1.67B
from 1.42B
Increased by 17.18%
Revenue Next Year
1.90B
from 1.67B
Increased by 14.02%
EPS This Year
0.07
from 0.02
Increased by 240.02%
EPS Next Year
0.16
from 0.07
Increased by 142.13%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | 2.0B | |
| Avg | 1.7B | 1.9B | |
| Low | 1.6B | 1.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.3% | 18.4% | |
| Avg | 17.2% | 14.0% | |
| Low | 12.0% | 8.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.11 | 0.27 | |
| Avg | 0.07 | 0.16 | |
| Low | 0.04 | 0.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 425.0% | 301.5% | |
| Avg | 240.0% | 142.1% | |
| Low | 96.0% | 58.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.